ZSAN [NASD]
Zosano Pharma Corporation
Index- P/E- EPS (ttm)-9.38 Insider Own0.40% Shs Outstand118.35M Perf Week17.27%
Market Cap8.65M Forward P/E- EPS next Y-0.09 Insider Trans-71.90% Shs Float118.14M Perf Month-27.26%
Income-29.90M PEG- EPS next Q-0.02 Inst Own7.20% Short Float0.32% Perf Quarter-76.21%
Sales0.80M P/S10.81 EPS this Y45.70% Inst Trans-0.92% Short Ratio0.79 Perf Half Y-91.12%
Book/sh9.69 P/B0.20 EPS next Y0.00% ROA-54.00% Target Price2.00 Perf Year-92.45%
Cash/sh2.46 P/C0.79 EPS next 5Y- ROE-78.90% 52W Range1.33 - 37.45 Perf YTD-88.24%
Dividend- P/FCF- EPS past 5Y- ROI-79.20% 52W High-94.83% Beta3.22
Dividend %- Quick Ratio1.00 Sales past 5Y- Gross Margin-1.40% 52W Low45.49% ATR0.25
Employees40 Current Ratio1.00 Sales Q/Q-50.00% Oper. Margin- RSI (14)34.58 Volatility7.75% 11.36%
OptionableNo Debt/Eq0.15 EPS Q/Q26.00% Profit Margin- Rel Volume0.15 Prev Close2.02
ShortableYes LT Debt/Eq0.03 Earnings- Payout- Avg Volume486.94K Price1.93
Recom1.70 SMA20-0.36% SMA50-55.42% SMA200-87.77% Volume73,294 Change-4.21%
Apr-17-19Initiated Maxim Group Buy $8
Mar-24-17Initiated Piper Jaffray Overweight $4
Aug-11-16Downgrade Ladenburg Thalmann Buy → Neutral
Nov-11-15Reiterated ROTH Capital Buy $11 → $7
Sep-29-15Reiterated ROTH Capital Buy $20 → $11
Feb-23-15Initiated ROTH Capital Buy $20
May-13-22 04:00PM  
May-03-22 05:50PM  
Apr-29-22 05:58PM  
04:00PM  
Apr-28-22 10:24AM  
Apr-11-22 08:00AM  
Mar-18-22 05:30PM  
Mar-17-22 04:05PM  
Feb-22-22 08:52AM  
Feb-08-22 09:55PM  
04:10PM  
Jan-27-22 01:38PM  
Jan-05-22 12:01PM  
10:06AM  
09:20AM  
Jan-03-22 07:37AM  
Dec-13-21 04:30PM  
Dec-08-21 11:53AM  
Nov-29-21 09:45PM  
Nov-17-21 05:49PM  
12:45PM  
08:00AM  
Nov-10-21 06:45PM  
04:10PM  
Oct-04-21 08:00AM  
Sep-02-21 04:30PM  
07:06AM  
Aug-10-21 06:25PM  
04:05PM  
Jul-20-21 08:30AM  
Jul-14-21 09:11AM  
Jun-11-21 09:35AM  
May-27-21 08:23AM  
May-26-21 04:05PM  
May-25-21 04:05PM  
May-12-21 04:05PM  
Apr-26-21 08:00AM  
Apr-16-21 01:52PM  
Mar-26-21 12:34PM  
Mar-11-21 04:05PM  
Mar-09-21 08:00PM  
Mar-02-21 08:30AM  
Feb-22-21 08:30AM  
Feb-01-21 08:30AM  
08:00AM  
Jan-12-21 09:08AM  
Jan-04-21 04:05PM  
08:30AM  
Dec-28-20 12:55PM  
11:59AM  
10:15AM  
10:00AM  
09:28AM  
Dec-27-20 01:00PM  
11:00AM  
Dec-26-20 03:09PM  
10:16AM  
09:35AM  
09:15AM  
Dec-25-20 09:00PM  
Dec-24-20 09:07PM  
05:18PM  
06:20AM  
Dec-23-20 10:15PM  
04:32PM  
03:00PM  
02:45PM  
02:08PM  
12:00PM  
11:00AM  
Dec-22-20 02:15PM  
12:45PM  
12:00PM  
11:30AM  
10:00AM  
09:00AM  
06:20AM  
Dec-21-20 09:00PM  
02:30PM  
01:42PM  
12:30PM  
11:30AM  
11:00AM  
06:14AM  
Dec-20-20 11:00AM  
Dec-19-20 05:19PM  
08:30AM  
Dec-18-20 07:01PM  
05:31PM  
12:30PM  
12:15PM  
11:58AM  
09:05AM  
08:00AM  
Dec-17-20 06:51PM  
05:19PM  
02:02PM  
12:35PM  
12:15PM  
11:30AM  
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matthews ChristineChief Financial OfficerMar 31Sale0.218,1161,705146,425Apr 01 09:09 PM
KELLERMAN DONALD JVP, Clinical Dev & Med AffairsMar 31Sale0.214,00684256,331Apr 01 09:08 PM
Lo StevenChief Executive OfficerMar 31Sale0.2123,6334,965460,709Apr 01 09:07 PM
GREATHOUSE KENNETHDirectorNov 23Sale0.6010,0006,01843,500Nov 24 05:53 PM
Lo StevenChief Executive OfficerJun 04Sale0.8113,15810,592365,592Jun 07 06:44 PM
Lewis HayleySee RemarksJun 04Sale0.811,7091,37649,779Jun 07 06:43 PM
Matthews ChristineChief Financial OfficerJun 04Sale0.811,7091,37698,291Jun 07 06:41 PM
KELLERMAN DONALD JVP, Clinical Dev & Med AffairsJun 04Sale0.811,7091,37650,337Jun 07 06:42 PM